Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Memory Impairment: early-phase trial registry
11 of 21 indexed Memory Impairment trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #797 of 28,707 conditions by registered trial count.
21 US clinical trials · 11 currently recruiting · #797 of 28,707 conditions by registered trial count
Memory Impairment: 21 US clinical trials tracked, 11 recruiting.
Memory Impairment is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Dartmouth-Hitchcock Medical Center, running 3 of these trials.
Enrollment posture brief
Registry condition memory-impairment
OPEN 11 | RECR 52% | LATE 1 | EARLY 3 | RANK #797 | SPON 3
Volume-matched condition peers
Nearest open-share peer: End-Stage Kidney Disease (52% recruiting · 21 trials)
Memory Impairment lists 11 open slots (52% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Memory Impairment on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Memory Impairment is recruiting above its size-band peers.
11 of 21 indexed trials (52.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Memory Impairment trials is spread across many organizations.
Dartmouth-Hitchcock Medical Center accounts for 3 of 21 trials (14.3%). 17 distinct sponsors appear on at least one study for this condition label.
-
Typical Memory Impairment enrolment sits around 125 participants.
Median target enrolment is 125 among the 21 trials that report a genuine target (sentinel values excluded). 10 of those (47.6%) plan for fewer than 100 participants.
-
Memory Impairment research is mostly interventional.
17 interventional and 4 observational studies make up this index (81% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
21 total, page 1 of 1
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
GAP Innovations, PBC
NCT06584357
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
Johns Hopkins University
NCT05663034
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
Arizona State University
NCT05877196
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
University of California, Berkeley
NCT05986604
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
United States Naval Medical Center, San Diego
NCT06413173
Brain Health Virtual Reality Study
University of California, San Diego
NCT06124339
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Dartmouth-Hitchcock Medical Center
NCT06930846
HOBSCOTCH-MS-Efficacy Trial
Dartmouth-Hitchcock Medical Center
NCT06951919
Neurobiological Mechanisms of Aging and Stress on Prospective Navigation
Georgia Institute of Technology
NCT03896529
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
Johns Hopkins University
NCT04601038
Assessing Cognitive Decline at Home
Stanford University
NCT06704971
Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey
C2N Diagnostics
NCT06025877
HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)
Dartmouth-Hitchcock Medical Center
NCT06391489
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
University of Washington
NCT01708304
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil
Wake Forest University Health Sciences
NCT02822573
Exercise for Memory Rehabilitation in Epilepsy
University of Alabama at Birmingham
NCT04959019
Noninvasive Brain Stimulation for Mild Cognitive Impairment
Palo Alto Veterans Institute for Research
NCT03331796
Mental Ability Challenge Study in Adults With and Without HIV
Vanderbilt University Medical Center
NCT03244488
The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers
AstraZeneca
NCT00985933
Effect of Insulin Sensitizer Metformin on AD Biomarkers
University of Pennsylvania
NCT01965756
Our Care Wishes - Dementia
University of Pennsylvania
NCT05033262
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Memory Impairment records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Memory Impairment trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Memory Impairment page
21 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 11 Memory Impairment trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dartmouth-Hitchcock Medical Center sponsors the most Memory Impairment trials on record, review their full trial history before evaluating a specific study. See Dartmouth-Hitchcock Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Memory Impairment condition card totals 21 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.